ELIZABETH URREA: Open Payments
NPI 1033802236 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 40 payments from 15 companies in 2025. Trend: 2023 $114 · 2024 $654 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $175 |
| Novo Nordisk Inc | 6 | $127 |
| UCB, Inc. | 2 | $76 |
| Dexcom, Inc. | 3 | $69 |
| Lilly USA, LLC | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Exact Sciences Corporation | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $29 |
Products named: UBRELVY, Dexcom G6 Transmitter, QULIPTA, Ozempic, MOUNJARO, VRAYLAR, Nayzilam, Cologuard Collection Kit.
Industry payments across OK — which companies pay providers there.
